Screener

Eligibility screening

Pembrolizumab, INCB081776, and Radiation Therapy for Head and Neck Squamous Cell Carcinoma

Sponsored by University of Wisconsin, MadisonStudy detailsClinicalTrials.gov

1 US site in WI

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.